ATOS

ATOS

USD

Atossa Therapeutics Inc. Common Stock

$0.756+0.006 (0.827%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.750

High

$0.764

Low

$0.726

Volume

0.00M

Company Fundamentals

Market Cap

97.7M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.63M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.55Current $0.756High $1.81

Related News

GlobeNewswire

Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio

SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today

View more
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio
Analyst Upgrades

Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.25

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7 to $7.25.

View more
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.25